Miriam W.
- Country
- Germany
- Department
- #2601: Hautklinik/ Clinical Research Center
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Oral Enpatoran in Adults With Active Cutaneous Lupus Erythematosus (with or without systemic disease)
- Efficacy of Deucravacitinib in Patients with Lichen Planus: A Multicenter, Phase II, Proof-of-Concept Study
- Efficacy and Safety Evaluation of Anifrolumab in Refractory Chronic and Subacute Cutaneous Lupus Erythematosus: A Phase III Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 13 of 119 partner sites.
Specializations
Cardiac Surgery Innovations
This investigator specializes in developing novel therapeutic approaches for high-risk cardiac surgery patients, with particular emphasis on preventive treatments for post-operative complications.
- Post-operative atrial fibrillation prevention
- Fish oil-based interventions
- Cardiac surgical recovery optimization
Critical Care Medicine
The investigator focuses on intensive care unit management of surgical patients, with particular attention to inflammatory response modulation and oxidative stress reduction.
- Systemic inflammatory response
- Antioxidant therapy
- Post-surgical care protocols
Therapeutic Supplementation
Research interests include the application of nutritional and antioxidant interventions in surgical settings, particularly investigating vitamin C and omega-3 fatty acids.
- Vitamin C therapeutics
- Lipid emulsion treatments
- Perioperative supplementation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.